Valley National Advisers’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.78M Buy
44,957
+75
+0.2% +$8.78K 0.64% 32
2026
Q1
$5.4M Sell
44,882
-26
-0.1% -$3K 0.7% 28
2025
Q4
$4.73M Sell
44,908
-1,645
-4% -$154K 0.65% 28
2025
Q3
$3.91M Buy
46,553
+25,843
+125% +$2.13M 0.61% 30
2025
Q2
$1.64M Buy
20,710
+1,019
+5% +$81K 0.27% 97
2025
Q1
$1.77M Buy
19,691
+9,111
+86% +$851K 0.32% 82
2024
Q4
$1.05M Sell
10,580
-559
-5% -$57.6K 0.19% 121
2024
Q3
$1.26M Sell
11,139
-10,824
-49% -$1.29M 0.23% 115
2024
Q2
$2.72M Sell
21,963
-804
-4% -$104K 0.4% 57
2024
Q1
$3M Sell
22,767
-80
-0.4% -$9.86K 0.45% 54
2023
Q4
$2.49M Buy
22,847
+191
+0.8% +$19.8K 0.4% 57
2023
Q3
$2.33M Sell
22,656
-1,042
-4% -$112K 0.41% 51
2023
Q2
$2.74M Sell
23,698
-1,214
-5% -$138K 0.46% 46
2023
Q1
$2.89M Buy
24,912
+1,457
+6% +$157K 0.51% 45
2022
Q4
$2.6M Sell
23,455
-676
-3% -$69.1K 0.47% 52
2022
Q3
$2.28M Sell
24,131
-947
-4% -$84.5K 0.48% 56
2022
Q2
$2.33M Buy
25,078
+1,698
+7% +$151K 0.49% 52
2022
Q1
$1.92M Buy
23,380
+8,899
+61% +$702K 0.37% 63
2021
Q4
$1.11M Buy
14,481
+439
+3% +$35K 0.2% 110
2021
Q3
$1.05M Sell
14,042
-208
-1% -$15.8K 0.19% 109
2021
Q2
$1.11M Sell
14,250
-648
-4% -$48.2K 0.2% 105
2021
Q1
$1.1M Buy
14,898
+572
+4% +$42.2K 0.21% 106
2020
Q4
$1.12M Buy
14,326
+521
+4% +$39.8K 0.23% 94
2020
Q3
$1.09M Sell
13,805
-1
-0% -$78 0.25% 67
2020
Q2
$1.02M Buy
13,806
+329
+2% +$24.8K 0.23% 73
2020
Q1
$989K Buy
13,477
+114
+0.9% +$8.96K 0.27% 69
2019
Q4
$1.16M Buy
13,363
+684
+5% +$56.2K 0.29% 70
2019
Q3
$1.02M Buy
12,679
+2,334
+23% +$187K 0.28% 72
2019
Q2
$828K Sell
10,345
-119
-1% -$9.11K 0.23% 81
2019
Q1
$830K Buy
10,464
+93
+0.9% +$6.96K 0.24% 81
2018
Q4
$756K Sell
10,371
-56
-0.5% -$3.95K 0.25% 80
2018
Q3
$706K Buy
10,427
+34
+0.3% +$2.17K 0.24% 88
2018
Q2
$602K Buy
10,393
+13
+0.1% +$733 0.23% 95
2018
Q1
$540K Buy
10,380
+776
+8% +$41.9K 0.2% 97
2017
Q4
$516K Sell
9,604
-1,201
-11% -$66.6K 0.18% 100
2017
Q3
$660K Buy
10,805
+162
+2% +$9.82K 0.23% 78
2017
Q2
$651K Hold
10,643
0.23% 74
2017
Q1
$645K Buy
10,643
+32
+0.3% +$1.94K 0.25% 75
2016
Q4
$596K Buy
10,611
+26
+0.2% +$1.52K 0.27% 85
2016
Q3
$630K Sell
10,585
-596
-5% -$34.9K 0.33% 84
2016
Q2
$615K Sell
11,181
-215
-2% -$11.4K 0.32% 85
2016
Q1
$575K Buy
11,396
+630
+6% +$30.9K 0.31% 85
2015
Q4
$543K Buy
10,766
+419
+4% +$21.1K 0.32% 80
2015
Q3
$488K Sell
10,347
-211
-2% -$11.2K 0.3% 90
2015
Q2
$574K Buy
10,558
+2,730
+35% +$153K 0.32% 85
2015
Q1
$429K Buy
7,828
+1,179
+18% +$66.8K 0.25% 94
2014
Q4
$318K Buy
+6,649
New +$370K 0.24% 84

Other funds holding MRK

Valley National Advisers's MRK Position: Q2 2026 in Review

Valley National Advisers increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $8.78K and bringing the position to 44,957 shares worth $5.78M. The position accounts for 0.64% of the portfolio, ranked #32.

Valley National Advisers first reported a position in MRK in Q4 2014 and has held it in 47 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Valley National Advisers held 44,957 shares of Merck worth $5.78M as of Q2 2026.
  • Valley National Advisers bought 75 Merck shares in Q2 2026, an estimated $8.78K.
  • Merck made up 0.64% of Valley National Advisers's portfolio in Q2 2026, its #32 holding.
  • Valley National Advisers first reported a position in Merck in Q4 2014 and has held it in 47 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.